221 related articles for article (PubMed ID: 1911340)
21. Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation.
Ayash LJ; Elias A; Hunt M; Demetri G; Wheeler C; Tepler I; Schwartz G; Mazanet R; Reich E; McCauley M
Br J Haematol; 1994 May; 87(1):153-61. PubMed ID: 7947240
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human erythropoietin in patients with myelodysplastic syndrome and myelofibrosis.
Mohr B; Herrmann R; Huhn D
Acta Haematol; 1993; 90(2):65-70. PubMed ID: 8285020
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group.
Remacha AF; Arrizabalaga B; Villegas A; Manteiga R; Calvo T; Julià A; Fernández Fuertes I; González FA; Font L; Juncà J; del Arco A; Malcorra JJ; Equiza EP; de Mendiguren BP; Romero M
Haematologica; 1999 Dec; 84(12):1058-64. PubMed ID: 10586205
[TBL] [Abstract][Full Text] [Related]
24. Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters.
Bowen DT; Culligan D; Beguin Y; Kendall R; Willis N
Leukemia; 1994 Jan; 8(1):151-5. PubMed ID: 8289479
[TBL] [Abstract][Full Text] [Related]
25. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes.
Merchav S; Nielsen OJ; Rosenbaum H; Sharon R; Brenner B; Tatarsky I; Scigalla P; Wieczorek L
Leukemia; 1990 Nov; 4(11):771-4. PubMed ID: 2232891
[TBL] [Abstract][Full Text] [Related]
26. The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes.
Verbeek W; Vehmeyer K; Wörmann B; Hiddemann W
J Cancer Res Clin Oncol; 1995; 121(6):338-42. PubMed ID: 7797598
[TBL] [Abstract][Full Text] [Related]
27. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
[TBL] [Abstract][Full Text] [Related]
29. rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors' response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow samples.
Rigolin GM; Porta MD; Bigoni R; Cavazzini F; Ciccone M; Bardi A; Cuneo A; Castoldi G
Br J Haematol; 2002 Dec; 119(3):652-9. PubMed ID: 12437640
[TBL] [Abstract][Full Text] [Related]
30. Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin (rh-Ep) in vitro in aplastic anemia and myelodysplastic syndrome.
Aoki I; Higashi K; Homori M; Chikazawa H; Ishikawa K
Am J Hematol; 1990 Sep; 35(1):6-12. PubMed ID: 2389770
[TBL] [Abstract][Full Text] [Related]
31. Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo).
Locatelli F; Canaud B; Giacardy F; Martin-Malo A; Baker N; Wilson J
Nephrol Dial Transplant; 2003 Feb; 18(2):362-9. PubMed ID: 12543893
[TBL] [Abstract][Full Text] [Related]
32. Darbepoetin alpha for the treatment of anemia in patients with myelodysplastic syndromes.
Giraldo P; Nomdedeu B; Loscertales J; Requena C; de Paz R; Tormo M; Navarro P; Benedit P; Gasquet JA;
Cancer; 2006 Dec; 107(12):2807-16. PubMed ID: 17115424
[TBL] [Abstract][Full Text] [Related]
33. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of hematopoiesis by amifostine in patients with myelodysplastic syndrome.
List AF; Brasfield F; Heaton R; Glinsmann-Gibson B; Crook L; Taetle R; Capizzi R
Blood; 1997 Nov; 90(9):3364-9. PubMed ID: 9345018
[TBL] [Abstract][Full Text] [Related]
35. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia.
Bessho M; Jinnai I; Matsuda A; Saito M; Hirashima K
Int J Cell Cloning; 1990 Nov; 8(6):445-58. PubMed ID: 2273298
[TBL] [Abstract][Full Text] [Related]
36. [Human recombinant erythropoietin in the treatment of myelodysplastic syndromes anemia. Meta-analytic study].
Rodríguez JN; Diéguez JC; Muñiz R; Martino ML; Fernández-Jurado A; Amian A; Cañavate M; Prados D
Sangre (Barc); 1994 Dec; 39(6):435-9. PubMed ID: 7855695
[TBL] [Abstract][Full Text] [Related]
37. Erythroid progenitor cell kinetics in chronic haemodialysis patients responding to treatment with recombinant human erythropoietin.
Reid CD; Fidler J; Oliver DO; Cotes PM; Pippard MJ; Winearls CG
Br J Haematol; 1988 Nov; 70(3):375-80. PubMed ID: 3207631
[TBL] [Abstract][Full Text] [Related]
38. The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin.
Bowen D; Culligan D; Jacobs A
Br J Haematol; 1991 Mar; 77(3):419-23. PubMed ID: 2012769
[TBL] [Abstract][Full Text] [Related]
39. A pilot trial of 13-cis-retinoic acid and alpha-tocopherol with recombinant human erythropoietin in myelodysplastic syndrome patients with progressive or transfusion-dependent anemias. The Central Pennsylvania Oncology Group.
Besa EC; Kunselman S; Nowell PC
Leuk Res; 1998 Aug; 22(8):741-9. PubMed ID: 9680102
[TBL] [Abstract][Full Text] [Related]
40. A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
Link H; Boogaerts MA; Fauser AA; Slavin S; Reiffers J; Gorin NC; Carella AM; Mandelli F; Burdach S; Ferrant A
Blood; 1994 Nov; 84(10):3327-35. PubMed ID: 7949088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
